Chapter 4.2 Flashcards

1
Q
  1. State the mechanism of action of the following drugs used to treat spasticity: diazepam
A

increases GABA mediated inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

baclofen MOA

A

stimulates GABA receptors in spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

tizanidine MOA

A

bind to alpha 2 receptors found primarily in CNS inhibiting small interneurons in neuronal pathways reducing activity of alpha motor neuron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

gabapentin MOA

A

inhibits calcium entry in presynaptic terminals decreasing release of glutamate and other excitatory neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dantrolene sodium MOA

A

inhibits release of calcium from skeletal muscle sarcoplasmic reticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

botulinum toxin MOA

A

injected locally for severe spasms and is a muscle paralytic. Mechanism is inhibits Ach release at skeletal NMJ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. State the other pharmacologic actions of diazepam that may be useful in treating patients with spasticity.
A

helpful with spasticity and anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. State the location for the intrathecal administration of baclofen.
A

subarachnoid space and is used for intense spasticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. State the patient populations primarily targeted for gabapentin therapy of spasticity.
A

MS, spinal cord injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. State the patient populations primarily targeted for botulinum toxin therapy for spasticity.
A

pasmodic torticollis, blepharospasm, laryngeal dystonia, strabismus, and several other types of focal dystonias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Identify the time course of botulin toxin activity in a patient with spasticity.
A

3-7 days and lasts 2-3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. List the key adverse effects associated with the following drugs used to treat spasticity: diazepam
A

sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

baclofen

A

decreasing excitation of alpha motor neurons and sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

gabapentin

A

may cause sedation, dizziness and ataxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dantrolene

A

liver toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

botulinum toxin

A

Carry over and long term effects on reflex activity in CNS. May cause death if it reaches the blood stream because it paralyzes all muscles

17
Q
  1. List some of the problems that may arise when a patient is using intrathecal baclofen via a pump delivery system
A

pump malfunction or a problem with the delivery catheter can occur. tolerance could develop with long-term, continuous baclofen administration.

18
Q
  1. State some of the benefits of botulinum toxin therapy when spastic dominance of a muscle group is reduced.
A

increased residual function like gait or posture, improved ADL, improved bracing

19
Q
  1. List the signs and symptoms of intrathecal baclofen overdose or withdrawal.
A

signs of overdose: decreased respiration and cardiac function, stupor and coma
Signs of withdrawal: fever, confusion, hallucinations and seizures

20
Q
  1. List the problems and limitation of botulinum toxin therapy.
A

local irritation at injection site, potential for antibody production, and signs of OD like drooping eyes, difficulty speak and swallowing, muscle weakness and respiratory distress

21
Q
  1. State the considerations of a physical therapy working with patients being treated for spasticity.
A

weakness, sedation and drastic change in muscle tone